297 related articles for article (PubMed ID: 236402)
21. Cancer topics: immunology and cancer revisited.
O'Brien PH
J S C Med Assoc; 1974 Jul; 70(7):223-6. PubMed ID: 4603086
[No Abstract] [Full Text] [Related]
22. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].
Trapeznikov NN; Iavorskiĭ VV; Kadagidze ZG; Malaev SG; Kupin VI
Vopr Onkol; 1977; 23(8):27-33. PubMed ID: 906404
[TBL] [Abstract][Full Text] [Related]
23. Intralesional BCG, intravenous immune lymphocytes, and immunization with neuraminidase-treated tumor cells to manage melanoma; A clinical assessment.
Seigler HF; Shingleton WW; Pickrell KL
Plast Reconstr Surg; 1975 Mar; 55(3):294-8. PubMed ID: 1118487
[TBL] [Abstract][Full Text] [Related]
24. Active specific and active non-specific immunotherapy in patients with malignant melanoma.
Kokoschka EM; Cerni C; Micksche M
Oncology; 1977; 34(5):229-33. PubMed ID: 917456
[TBL] [Abstract][Full Text] [Related]
25. The immunotherapy of cancer.
Parker CW
Pharmacol Rev; 1973 Jun; 25(2):325-42. PubMed ID: 4581047
[No Abstract] [Full Text] [Related]
26. Immunotherapy of malignancies: current status.
Eilber FR; Holmes EC; Morton DL; Ramming KP; Sparks FC
AJR Am J Roentgenol; 1976 May; 126(5):1088-93. PubMed ID: 178234
[TBL] [Abstract][Full Text] [Related]
27. [Clinical trial of immunotherapy for cancer].
Adler A; Stein JA; Maor M
Harefuah; 1972 Dec; 83(12):513-7. PubMed ID: 4659015
[No Abstract] [Full Text] [Related]
28. Successful immunotherapy by dinitrochlorobenzene in a case of recurrent acrolentiginous melanoma.
Sigg C; Schnyder UW
Dermatologica; 1990; 181(3):250-1. PubMed ID: 2269391
[No Abstract] [Full Text] [Related]
29. Cryosurgery and immunotherapy for prostatic cancer.
Loening S; Lubaroff D
Urol Clin North Am; 1984 May; 11(2):327-36. PubMed ID: 6203207
[TBL] [Abstract][Full Text] [Related]
30. Manipulation of host resistance in cancer therapy.
Baldwin RW
Springer Semin Immunopathol; 1982; 5(2):113-25. PubMed ID: 6755781
[No Abstract] [Full Text] [Related]
31. Immunotherapy for human malignant melanoma.
Kopf AW
South Med J; 1975 Apr; 68(4):495-503. PubMed ID: 1124416
[TBL] [Abstract][Full Text] [Related]
32. Nonspecific antigen reactions.
Klein E; Rosner D; Holtermann OA; Stoll HL; Song SY
Natl Cancer Inst Monogr; 1976 Nov; 44():87-97. PubMed ID: 799764
[TBL] [Abstract][Full Text] [Related]
33. Immunotherapy of melanoma.
Nathanson L
J Cutan Pathol; 1979 Jun; 6(3):213-26. PubMed ID: 383755
[TBL] [Abstract][Full Text] [Related]
34. Immunotherapy from malignant disease.
Goodnight JE; Morton DL
Annu Rev Med; 1978; 29():231-83. PubMed ID: 348035
[No Abstract] [Full Text] [Related]
35. Perspectives in immunotherapy of lung cancer.
Hersh EM; Gutterman JU; Mavligit GM
Cancer Treat Rev; 1974 Mar; 1(1):65-80. PubMed ID: 4471091
[No Abstract] [Full Text] [Related]
36. Immunotherapy with dinitrochlorobenzene (DNCB) for recurrent squamous cell tumor of conjunctiva.
Ferry AP; Meltzer MA; Taub RN
Trans Am Ophthalmol Soc; 1976; 74():154-71. PubMed ID: 325854
[TBL] [Abstract][Full Text] [Related]
37. Immunotherapy of melanoma with intralesional BCG.
Bornstein RS; Mastrangelo MJ; Sulit H; Chee D; Yarbro JW; Prehn LM; Prehn RT
Natl Cancer Inst Monogr; 1973 Dec; 39():213-20. PubMed ID: 4595320
[No Abstract] [Full Text] [Related]
38. BCG immunotherapy of malignant melanoma: summary of a seven-year experience.
Morton DL; Eilber FR; Holmes EC; Hunt JS; Ketcham AS; Silverstein MJ; Sparks FC
Ann Surg; 1974 Oct; 180(4):635-43. PubMed ID: 4412271
[TBL] [Abstract][Full Text] [Related]
39. Immunotherapy in childhood cancer.
Leventhal BG
Pediatr Ann; 1978 Aug; 7(8):570-4. PubMed ID: 693076
[No Abstract] [Full Text] [Related]
40. Re-inventing intratumoral immunotherapy for melanoma.
Triozzi PL; Tuthill RJ; Borden E
Immunotherapy; 2011 May; 3(5):653-71. PubMed ID: 21554094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
